EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors

Saade Abdalkareem Jasim, Abdulrahman T Ahmed, Aziz Kubaev, Ashishkumar Kyada, Mohammad Y Alshahrani, Shilpa Sharma, Hussein Riyadh Abdul Kareem Al-Hetty, Raghav Vashishth, Ashish Singh Chauhan, Munther Kadhim Abosaoda

Medical Oncology · 2024

DOI: 10.1007/s12032-024-02529-9 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Oncology, 2024. Verfasst von Saade Abdalkareem Jasim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory Techniques Department, Al-Maarif University College, Ramadi, Anbar, Iraq. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Neoplasms, Signal Transduction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 185 Literaturangaben. Gefördert von: King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MicroRNAs (miRNAs) are conserved non-protein-coding RNAs that are naturally present in organisms and can control gene expression by suppressing the translation of mRNA or causing the degradation of mRNA. MicroRNAs are highly concentrated in the PI3K/AKT pathway, and abnormal activation of the PI3K/AKT pathway plays a role in cancer progression. The AKT/PI3K pathway is critical for cellular functions and can be stimulated by cytokines and in normal situations. It is involved in regulating various intracellular signal transduction, including development, differentiation, transcriptional regulation, protein, and synthesis. There is a growing body of evidence indicating that miRNAs, which are abundant in exosomes released by different cells, can control cellular biological activities via modulating the PI3K/AKT pathway, hence influencing cancer progression and drug resistance. This article provides an overview of the latest research progress regarding the function and medical use of the PI3K/AKT pathway and exosomal miRNA/AKT/PI3K axis in the behaviors of cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExosomesNeoplasmsSignal TransductionHumansAnimalsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinaseDrug Resistance, NeoplasmGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AKTCancerExosomePI3KmiRNA

Substanzen

MicroRNAsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinase

Autor:innen und Institutionen

  • Medical Laboratory Techniques Department, Al-Maarif University College, Ramadi, Anbar, Iraq.
  • Biotechnology Department, College of Applied Science, Fallujah University, Anbar, Iraq.
  • Department of Nursing, Al-Maarif University College, AL-Anbar Governorate, Ramadi, Iraq. Abdulrahman.dheyab@uoa.edu.iq.
  • Department of Maxillofacial Surgery, Samarkand State Medical University, 18 Amir Temur Street, 140100, Samarkand, Uzbekistan.
  • Department of Pharmacy, Faculty of Health Sciences, Marwadi University, Rajkot, Gujarat, 360003, India.
  • King Khalid University, AlQura'a, P.O. Box 960, Abha, Saudi Arabia.

Förderung

  • King Khalid University

Zitieren

APA

Jasim, S. A., Ahmed, A. T., Kubaev, A., Kyada, A., Alshahrani, M. Y., Sharma, S., Al-Hetty, H. R. A. K., Vashishth, R., Chauhan, A. S., & Abosaoda, M. K. (2024). Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors. Medical Oncology. https://doi.org/10.1007/s12032-024-02529-9

Vancouver

Jasim SA, Ahmed AT, Kubaev A, Kyada A, Alshahrani MY, Sharma S, et al. Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors. Medical Oncology. 2024. doi:10.1007/s12032-024-02529-9

BibTeX
@article{Jasim2024,
  author = {Jasim, Saade Abdalkareem and Ahmed, Abdulrahman T and Kubaev, Aziz and Kyada, Ashishkumar and Alshahrani, Mohammad Y and Sharma, Shilpa and Al-Hetty, Hussein Riyadh Abdul Kareem and Vashishth, Raghav and Chauhan, Ashish Singh and Abosaoda, Munther Kadhim},
  title = {Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors},
  journal = {Medical Oncology},
  year = {2024},
  doi = {10.1007/s12032-024-02529-9}
}
Kostenlos starten →